MedTrace Logo

Physically Active During Cancer Treatment (FAKT)

NCT03885817 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2025-06-05

No results posted yet for this study

Summary

This randomized controlled trial aims to investigate whether an individually tailored exercise program and nutritional guide can affect the development of self-reported peripheral sensory neuropathy and fatigue in patients with colorectal cancer receiving adjuvant chemotherapy.

Conditions

  • Neoplasms, Colorectal

Interventions

BEHAVIORAL

Exercise training and nutritional guide

30 minutes of a combination of sensorimotor- and strength training guided by a physical therapist twice a week. In addition 90 minutes a week of moderate intensity aerobic training or 45 minutes a week of high intensity aerobic training. Once a month the participants will fill out the form, PG-SGA SF, and he or she will be referred to a nutritionist if the score is 2 or higher. The intervention period lasts as long as the participants receives adjuvant chemotherapy, i.e. 3 - 6 months.

OTHER

Standard follow-up care

standard recommendations regarding physical activity and nutrition during the period with adjuvant chemotherapy.

Sponsors & Collaborators

  • Alesund Hospital

    collaborator OTHER

  • Helse Nord-Trøndelag HF

    collaborator OTHER

  • Ullevaal University Hospital

    collaborator OTHER

  • Sorlandet Hospital HF

    collaborator OTHER_GOV

  • Asker & Baerum Hospital

    collaborator OTHER

  • Haukeland University Hospital

    collaborator OTHER

  • St. Olavs Hospital

    lead OTHER

Principal Investigators

  • Arne Solberg, md phd · St. Olavs Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-27
Primary Completion
2022-09-13
Completion
2027-06-30

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03885817 on ClinicalTrials.gov